Search

everythinglearnresearchcommunity

for

Search:↓

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

The model and estimator can predict drug exposure in kidney transplant patients well.

The supplement highlighted advancements and challenges in plastic and reconstructive surgery, including the impact of smoking, chemotherapy, and new treatments like Tafluprost for hair loss.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Ageratum Conyzoides, when taken orally, can effectively reduce hair loss and improve hair growth.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Sertraline, an antidepressant, may rarely cause hair loss.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Sertraline, an antidepressant, may cause hair loss in rare cases.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.